Steinberg Global Asset Management’s AbbVie ABBV Stock Holding History

Steinberg Global Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.14M	Sell	14,129 -48,114	-77%	-$3.94M	0.18%	123
2018 Q4	$5.74M	Sell	62,243 -2,363	-4%	-$208K	0.99%	30
2018 Q3	$6.11M	Buy	64,606 +1,675	+3%	+$159K	0.87%	37
2018 Q2	$5.83M	Sell	62,931 -4,707	-7%	-$460K	0.86%	38
2018 Q1	$6.4M	Sell	67,638 -12,880	-16%	-$1.41M	0.94%	33
2017 Q4	$7.79M	Sell	80,518 -1,932	-2%	-$182K	1.12%	28
2017 Q3	$7.33M	Sell	82,450 -16,121	-16%	-$1.23M	1.08%	28
2017 Q2	$7.15M	Buy	98,571 +3,112	+3%	+$209K	1.09%	32
2017 Q1	$6.22M	Sell	95,459 -27,185	-22%	-$1.71M	0.98%	36
2016 Q4	$7.68M	Buy	122,644 +5,869	+5%	+$358K	1.29%	22
2016 Q3	$7.37M	Buy	116,775 +658	+0.6%	+$42.6K	1.24%	27
2016 Q2	$7.19M	Buy	116,117 +9,647	+9%	+$588K	1.25%	32
2016 Q1	$6.08M	Buy	106,470 +2,684	+3%	+$150K	1.14%	35
2015 Q4	$6.15M	Sell	103,786 -443	-0.4%	-$25.5K	1.2%	29
2015 Q3	$5.67M	Buy	104,229 +4,398	+4%	+$286K	1.12%	31
2015 Q2	$6.71M	Buy	99,831 +2,369	+2%	+$155K	1.28%	21
2015 Q1	$5.71M	Buy	97,462 +18,805	+24%	+$1.14M	1.15%	31
2014 Q4	$5.15M	Sell	78,657 -6,119	-7%	-$386K	1.11%	32
2014 Q3	$4.9M	Buy	84,776 +5,767	+7%	+$320K	1.12%	30
2014 Q2	$4.46M	Buy	79,009 +4,141	+6%	+$217K	1.04%	34
2014 Q1	$3.85M	Buy	74,868 +5,770	+8%	+$292K	0.96%	36
2013 Q4	$3.65M	Buy	69,098 +2,570	+4%	+$126K	0.78%	41
2013 Q3	$2.98M	Sell	66,528 -2,350	-3%	-$104K	0.66%	44
2013 Q2	$2.85M	Buy	+68,878	New	+$3.01M	0.74%	41

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Steinberg Global Asset Management's ABBV Position: Q1 2019 in Review

Steinberg Global Asset Management reduced its AbbVie (ABBV) stake by 77% in Q1 2019, selling an estimated $3.94M and leaving 14,129 shares worth $1.14M. The position accounts for 0.18% of the portfolio, ranked #123.

Steinberg Global Asset Management first reported a position in ABBV in Q2 2013 and has held it in 24 quarters since. The position peaked at $7.79M in Q4 2017. 2,033 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

Steinberg Global Asset Management held 14,129 shares of AbbVie worth $1.14M as of Q1 2019.
Steinberg Global Asset Management sold 48,114 AbbVie shares in Q1 2019, an estimated $3.94M.
AbbVie made up 0.18% of Steinberg Global Asset Management's portfolio in Q1 2019, its #123 holding.
Steinberg Global Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 24 quarters since.
Steinberg Global Asset Management's AbbVie position peaked at $7.79M in Q4 2017.
2,033 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Steinberg Global Asset Management's 13F filing for Q1 2019, filed 15 Apr 2019.